Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 11:40 am Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | BIOTECHNOLOGY VALUE FUND L P | 3,276,543 4.9% | -591,500 (-15.29%) | View |
| 2023-02-13 5:06 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Foresite Capital Fund IV L.P. | 4,066,277 6.1% | 4,066,277 (New Position) | View |
| 2023-02-06 2:43 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | WELLINGTON MANAGEMENT GROUP LLP | 5,484,013 8.22% | -55,255 (-1.00%) | View |
| 2023-01-31 1:58 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | BlackRock Inc. BLK | 5,087,435 7.6% | 1,008,560 (+24.73%) | View |
| 2022-04-25 4:30 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | RA CAPITAL MANAGEMENT L.P. | 4,398,453 7.1% | 4,398,453 (New Position) | View |
| 2022-02-14 6:22 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Rock Springs Capital Management LP | 3,861,347 6.31% | 1,185,247 (+44.29%) | View |
| 2022-02-14 4:13 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Venrock Healthcare Capital Partners II L.P. | 4,563,962 7.5% | 4,563,962 (New Position) | View |
| 2022-02-11 3:12 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | Foresite Capital Fund III L.P. | 4,657,277 7.6% | -1,954,904 (-29.57%) | View |
| 2022-02-10 2:17 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | RENAISSANCE TECHNOLOGIES LLC | 1,676,878 2.74% | -1,591,300 (-48.69%) | View |
| 2022-02-10 08:54 am Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 899,997 1.47% | -1,350,003 (-60.00%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | BlackRock Inc. BLK | 4,078,875 6.7% | 3,031,059 (+289.27%) | View |
| 2022-02-04 09:12 am Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | WELLINGTON MANAGEMENT GROUP LLP | 5,539,268 9.05% | 5,539,268 (New Position) | View |
| 2022-01-24 5:23 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | BIOTECHNOLOGY VALUE FUND L P | 3,868,043 6.3% | 3,868,043 (New Position) | View |
| 2021-02-16 4:32 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Rock Springs Capital Management LP | 2,676,100 6.24% | 462,244 (+20.88%) | View |
| 2021-02-12 3:18 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | EcoR1 Capital LLC | 1,509,812 3.5% | -577,500 (-27.67%) | View |
| 2021-02-11 2:56 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Foresite Capital Fund III L.P. | 6,612,181 13.7% | 4,381,241 (+196.39%) | View |
| 2021-02-11 07:29 am Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,250,000 5.24% | -250,000 (-10.00%) | View |
| 2021-02-10 8:48 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | RENAISSANCE TECHNOLOGIES LLC | 3,268,178 7.61% | 485,881 (+17.46%) | View |
| 2020-10-26 7:47 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Foresite Capital Fund III L.P. | 2,230,940 5.2% | 2,230,940 (New Position) | View |
| 2020-10-26 4:49 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Rock Springs Capital Management LP | 2,213,856 5.18% | 613,856 (+38.37%) | View |